site stats

Clinicaltrials.gov 中文

WebApr 14, 2024 · A clinical answer successful induction therapy will be set according to the maximum temperature (ºC) daily 72 hours and no increase in the severity of clinical signs, symptoms or laboratory abnormalities attributable to histoplasmosis (e.g., weight instabilities (kg), blood pressure (mmHg) and blood oxygen level (mg/L)).The primary outcome will …

How to Use Advanced Search - ClinicalTrials.gov

WebJun 15, 2024 · ClinicalTrials.gov Identifier: NCT04927065 Other Study ID Numbers: mRNA-1273-P205 : First Posted: June 15, 2024 Key Record Dates: Last Update Posted: November 18, 2024 Last Verified: November 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... WebDec 10, 2024 · ClinicalTrials.gov Identifier: NCT05153330 Other Study ID Numbers: COVALENT-101 : First Posted: December 10, 2024 Key Record Dates: Last Update Posted: February 27, 2024 Last Verified: February 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Layout table for additional information ... paytm entertainment twitter https://lezakportraits.com

Efficacy and Safety of High-dose L-AmB for ... - clinicaltrials.gov

ClinicalTrials.gov is a registry of clinical trials. It is run by the United States National Library of Medicine (NLM) at the National Institutes of Health, and holds registrations from over 444,000 trials from 221 countries. WebApr 12, 2024 · ClinicalTrials.gov Identifier: NCT05809687 Other Study ID Numbers: DKP21102_301 : First Posted: April 12, 2024 Key Record Dates: Last Update Posted: April 12, 2024 Last Verified: March 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Layout table for additional information ... WebA ClinicalTrials.gov staff member will review the study record after it is released (submitted) and before it is published on ClinicalTrials.gov. This review will focus on apparent validity (when possible), meaningful entries, logic and internal consistency, and formatting. You may be asked to clarify items or make corrections to the record ... scripting in windows

Clinical Study on Third-line Treatment of Advanced Duodenal ...

Category:Efficacy and Safety of High-dose L-AmB for ... - clinicaltrials.gov

Tags:Clinicaltrials.gov 中文

Clinicaltrials.gov 中文

Advanced Search - ClinicalTrials.gov

WebJun 11, 2024 · ClinicalTrials.gov Identifier: NCT04923893 Other Study ID Numbers: CR109015 2024-001242-35 ( EudraCT Number ) 68284528MMY3004 ( Other Identifier: Janssen Research & Development, LLC ) First Posted: June 11, 2024 Key Record Dates: Last Update Posted: February 24, 2024 Last Verified: February 2024 WebApr 12, 2024 · ClinicalTrials.gov: If an award provides for one or more clinical trials. By law (Title VIII, Section 801 of Public Law 110-85), the "responsible party" must register and submit results information for certain “applicable clinical trials” on the ClinicalTrials.gov Protocol Registration and Results System Information Website ...

Clinicaltrials.gov 中文

Did you know?

WebAug 18, 2024 · ClinicalTrials.gov Identifier: NCT05011513 Other Study ID Numbers: C4671002 2024-002857-28 ( EudraCT Number ) EPIC-SR ( Other Identifier: Alias Study Number ) First Posted: August 18, 2024 Key Record Dates: Last Update Posted: December 12, 2024 Last Verified: December 2024 WebThe Final Rule for Clinical Trials Registration and Results Information Submission (42 CFR Part 11) clarifies and expands the regulatory requirements and procedures for submitting registration and results information for certain clinical trials to ClinicalTrials.gov, in accordance with Section 801 of the Food and Drug Administration Amendments ...

WebSep 2, 2024 · ClinicalTrials.gov Identifier: NCT05527184 Other Study ID Numbers: IMGN151-1001 : First Posted: September 2, 2024 Key Record Dates: Last Update Posted: March 13, 2024 Last Verified: September 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... WebApr 12, 2024 · Inclusion Criteria: Patients must meet all of the following criteria to be eligible for inclusion: Age between 18 and 80 years (inclusive); Imaging findings consistent with unresectable local advanced, recurrent or metastatic duodenal adenocarcinoma; Histologically confirmed unresectable local advanced, recurrent or metastatic duodenal …

WebApr 13, 2024 · ClinicalTrials.gov Identifier: NCT05811247 Other Study ID Numbers: APC-APN-304 : First Posted: April 13, 2024 Key Record Dates: Last Update Posted: April 13, 2024 Last Verified: March 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... WebApr 5, 2024 · This study is a Phase 1, multicenter, open-label study designed to evaluate the safety and efficacy of MT-601 in patients with relapsed or refractory Non-Hodgkin lymphoma (NHL) who either received CD19+ chimeric antigen receptor (CAR) T cell therapy or are ineligible for CD19+ CAR T cell therapy.

WebClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants conducted around the world. Explore 448,252 …

WebApr 13, 2024 · ClinicalTrials.gov Identifier: NCT05811481 Other Study ID Numbers: [2024]662 : First Posted: April 13, 2024 Key Record Dates: Last Update Posted: April 13, 2024 Last Verified: April 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Plan Description: ... scripting in windows 10WebApr 17, 2024 · Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number): Perez-Garcia J, Soberino J, Racca F, Gion M, Stradella A, Cortes J. Atezolizumab in the treatment of metastatic triple-negative breast cancer. Expert Opin Biol Ther. 2024 Sep;20(9):981-989. doi: 10.1080/14712598.2024.1769063. paytm electricity bill payment onlineWebNov 6, 2024 · ClinicalTrials.gov Identifier: NCT04153149 Other Study ID Numbers: ALN-TTRSC02-003 2024-003153-28 ( EudraCT Number ) First Posted: November 6, 2024 Key Record Dates: Last Update Posted: March 21, 2024 Last Verified: March 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No paytm employee countWebJul 11, 2024 · ClinicalTrials.gov Identifier: NCT03212404 Other Study ID Numbers: CK-301-101 : First Posted: July 11, 2024 Key Record Dates: Last Update Posted: March 4, 2024 Last Verified: March 2024 Layout table for additional information; Studies a U.S. FDA-regulated Drug Product: ... paytm employee benefitsWebNov 6, 2024 · ClinicalTrials.gov [ How to Use Search] This is a searchable registry and results database of federally and privately supported clinical trials conducted in the … paytm equity shareWebFill in any or all of the fields below. Click on the label to the left of each search field for more information or read the Help. Condition or disease: Other terms: Study type: Study Results: Status: Recruitment: Not yet recruiting. paytm establishedWebApr 14, 2024 · A clinical answer successful induction therapy will be set according to the maximum temperature (ºC) daily 72 hours and no increase in the severity of clinical … paytm eligibility criteria